Phosphorylated Akt is detectable and associated with a poor prognosis in multiple human cancers, such as non-small cell lung cancer, breast cancer and acute lymphoblastic leukemia [12], [18]–[19]. This evidence concerns the gene AKT1 and breast carcinoma.